{"text": ["After", "Hours", "Most", "Active", "for", "Jun", "1,", "2018", ":", "", "ODP,", "PRSP,", "GME,", "ATUS$,", "QQQ,", "OKTA,", "ABBV,", "FOXA,", "GDDY,", "GM,", "ZNGA,", "MSFT"], "created_at": "2018-06-01 20:57:27"}
{"text": ["After", "Hours", "Most", "Active", "for", "Jun", "1,", "2018", ":", "", "ODP,", "PRSP,", "GME,", "ATUS$,", "QQQ,", "OKTA,", "ABBV,", "FOXA,", "GDDY,", "GM,", "ZNGA,", "MSFT"], "created_at": "2018-06-01 20:57:27"}
{"text": ["Phase", "3", "IMBRUVICA\u00ae", "(ibrutinib)", "Data", "Suggest", "Improved", "Treatment", "Outcomes", "in", "Waldenstr\u00f6m's", "Macroglobulinemia", "(WM),", "a", "Rare", "Form", "of", "Blood", "Cancer,", "in", "Combination", "with", "Rituximab", "versus", "Rituximab", "Alone"], "created_at": "2018-06-01 20:45:00"}
{"text": ["How", "Novartis,", "Insurers", "Are", "Taking", "Wind", "Out", "Of", "AbbVie&apos;s", "Sales"], "created_at": "2018-06-01 17:47:23"}
{"text": ["Solid", "Month", "Ends", "with", "New", "Round", "of", "Trade", "Fears"], "created_at": "2018-06-01 14:07:50"}
{"text": ["Solid", "Month", "Ends", "with", "New", "Round", "of", "Trade", "Fears"], "created_at": "2018-06-01 14:07:50"}
{"text": ["Solid", "Month", "Ends", "with", "New", "Round", "of", "Trade", "Fears"], "created_at": "2018-06-01 13:15:01"}
{"text": ["Novartis,", "aiming", "to", "go", "toe-to-toe", "with", "Humira,", "wins", "EU", "panel", "nod"], "created_at": "2018-06-01 13:03:05"}
{"text": ["Novartis,", "aiming", "to", "go", "toe-to-toe", "with", "Humira,", "wins", "EU", "panel", "nod"], "created_at": "2018-06-01 12:54:59"}
